Scope
Reference
C366698
Description
Project title: NHS National Framework for Golimumab Injection commencing 1st November 2025 Offer reference number: CM/TNS/25/5724 Period of framework: 1 November 2025 to 31 October 2026 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 48 months. Published By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England
Commercial tool
Establishes a framework
Total value (estimated)
- £90,000,000 excluding VAT
- £108,000,000 including VAT
Above the relevant threshold
Contract dates (estimated)
- 1 November 2025 to 31 October 2026
- Possible extension to 31 October 2029
- 4 years
Main procurement category
Goods
CPV classifications
- 33600000 - Pharmaceutical products
Contract locations
- UKC - North East (England)
- UKD - North West (England)
- UKF - East Midlands (England)
- UKG - West Midlands (England)
- UKH - East of England
- UKJ - South East (England)
- UKK - South West (England)
Engagement
Engagement deadline
19 June 2025
Engagement process description
NHS England is seeking to engage with suppliers that are planning to launch golimumab injection. Interested suppliers will be invited to a virtual 1:1 preliminary market engagement meeting. The purpose of these sessions is to update suppliers regarding timelines and to discuss product details, product launches during the proposed framework period, tender structure, and KPI's. Please contact katie.noonan@nhs.net or marie.graney1@nhs.net to register your interest in tendering for this framework.
Participation
Particular suitability
Small and medium-sized enterprises (SME)
Submission
Publication date of tender notice (estimated)
27 June 2025
Contracting authority
NHS England
- Public Procurement Organisation Number: PDPT-3135-BWWY
Wellington House, 133-135 Waterloo Rd
London
SE1 8UG
United Kingdom
Email: katie.noonan@nhs.net
Website: https://www.england.nhs.uk/
Region: UKI45 - Lambeth
Organisation type: Public authority - central government